IHI:NYE-iShares U.S. Medical Devices ETF (USD)

ETF | Health |

Last Closing

USD 59.42

Change

+0.30 (+0.51)%

Market Cap

N/A

Volume

0.28M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-23 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.88 (-0.57%)

USD 42.10B
FHLC Fidelity® MSCI Health Care In..

-0.31 (-0.42%)

USD 3.01B
FXH First Trust Health Care AlphaD..

-0.26 (-0.23%)

USD 1.29B
XHE SPDR® S&P Health Care Equipme..

-0.36 (-0.40%)

USD 0.23B
IDNA iShares Genomics Immunology an..

-0.46 (-1.85%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

-0.94 (-2.41%)

USD 0.12B
XHS SPDR® S&P Health Care Service..

-0.13 (-0.13%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.22 (-0.76%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

-1.75 (-2.72%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-1.14 (-3.89%)

USD 0.01B

ETFs Containing IHI

ETAC:CA 0.00 % 1.76 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.10% 52% F 58% F
Dividend Return 0.16% 31% F 2% F
Total Return 10.25% 52% F 50% F
Trailing 12 Months  
Capital Gain 21.56% 76% C+ 64% D
Dividend Return 0.84% 50% F 10% F
Total Return 22.41% 81% B- 58% F
Trailing 5 Years  
Capital Gain 44.13% 48% F 68% D+
Dividend Return 2.31% 44% F 7% C-
Total Return 46.44% 48% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 6.41% 52% F 60% D-
Dividend Return 6.80% 52% F 53% F
Total Return 0.40% 47% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 19.82% 43% F 52% F
Risk Adjusted Return 34.34% 52% F 52% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.